Journal Register (JRC) Cotización

You need to watch the trading on Level II to understand what's going on - this gets dropped down at low volume early in the trading day, and somehow it is held down while massive accumulation is going on in the mid-20s, drove it up to .26 at close today. But you'll always notice how sells at bid take out the bids, but buys at ask of 50,000 shares won't take out a 5000 share ask.

The drop on Friday was orchestrated so they could accumulate at lower levels. This is all a game - it's either shorts trying to cover at lower levels, or accumulators trying to accumulate at lower levels. If they wanted this thing to tank, it would have tanked when the PR came out about NYSE delisting, or it would have tanked yesterday after the Friday crash. You just need to be patient with these, this thing could take off like a rocket at any given moment. Based on the fact that this has not crashed below .20, I think they are trying to accumulate and will let it run.

Secolton, man dont knwo what to think anymore. Again MM's playing ??? whatever profit i made, seems is drifting away from my hands...Was up over 30%

Back to .30 today on nice volume, I knew the crash Friday was orchestrated. . .

last week .13 and .45 2 days ago. So profit takers we no were coming...after everything settles i see us having a nice run back. Same thing happened to IQW and then it ran hard

i am holding too. But if we touches .40 i am selling everything...

No clue, it was very strange - they kept hitting the bid with 5000 share sales - this same exact thing happened to another one of my stocks, HDLM, at the same exact time today - both were NYSE delisted stocks trading on OTC. I'm not sure if both Market Makers or institutions crashed both just to pick up cheaper shares or what - I'm holding on to mine here.

total collapse. 24 cents. What happened ?????

Gap or not, once impairement is off the books..

"Excluding the impairment charges and the other items discussed above, 2007 net income would have been $3.9 million, or $0.10 per diluted share, for the fourth quarter and $15.3 million, or $0.39 Excluding the impairment charges and the other items discussed above, 2007 net income would have been $3.9 million, or $0.10 per diluted share, for the fourth quarter and $15.3 million, or $0.39 per diluted share, for the full year 2007."

Lazards very good at pointing out those portions of a company which need to be let go, as case in point, the certain 7 mill$ in wage management employees let go, along with the lear jet,lol.

Looks to me like the shorts gotta hold of this one and executed perfectly. Way oversold from 4th qrt results and NYSE delisting news, IMO.

No debt payments for a year, and with a little restructure,
the per diluted share should hold or go up some. Again, one would think the employee count, 100 mill in revs, assets and per diluted makes valuations north of here.

I think tomorrow AM will be a gap up - good close today

Maybe all the brokers will have l2 b/a prices also. TD says tomarro. Has been plenty of buying interest, sellers just keep pushing back.

Hit .45 this morning than dropped back down, I'm feeling upper .40s, low .50s in early morning tomorrow.

agree, doing great in pinks

Very interesting trading on this today, dipped to .29 then shot up like a rocket to .35 - I think it is shorts trying to cover still, they buy in waves and then stop for a while and let the price drift back down. I could see .40s or .50s on this by the end of the week.

WE CLOSED GREEN AGAIN.. .335 !! UP .015 TOMORROW I SAY WE SEE
.35 AGAIN AND MAYBE HIGHER...WILL THIS FLY LIKE "IQW" ?

JRCO New Symbol Low float , institutionals buying , SHORTERs OVER SOLD . DESESPERATES !

I tend to agree a takeover is in the works. Look at MEG, huge fund bought up shares and now wants seats on the board. For 10 million here, you could have the whole company. Don't let the market fool you, newspapers are still huge cash cows and attractive investments, espcially if you can take them private.

Was asked for this on the Coolsters board figured I put it here for you as well

to remember, institutional buys are huge. check:

http://www.cnbc.com/id/15837275?q=jrc

shorters covering and rumors of a buyout NICE!

buyout is why pps raising imo

That is the old PR, this was released today:

Journal Register Company Receives NYSE Delisting Notification
Monday April 14, 5:28 pm ET


YARDLEY, PA--(MARKET WIRE)--Apr 14, 2008 -- Journal Register Company (NYSE:JRC - News) announced today that the New York Stock Exchange (the "NYSE") intends to suspend trading in the Company's common stock prior to the NYSE's opening on April 16, 2008 and that the NYSE will commence procedures to delist the Company's common stock. The NYSE determined to suspend trading based on the abnormally low trading price for the common stock, which closed at $0.265 on April 11, 2008. The Company does not intend to take any further action to appeal the NYSE's decision and therefore, it is expected that the common stock will be delisted after completion by the NYSE of application to the Securities and Exchange Commission. The Company expects trading in its common stock will be transferred to the over-the-counter market following the suspension of trading on the NYSE.




Shorts will want to cover while JRC is still listed on the NYSE because they run more of a risk trying to cover on the OTC, never know what might happen on the OTC because there are different market makers, and there can be very wild price swings.

I read something from Dr.Luck and didn't pay attention to its date. Yes, it seems the co. will delist or get bought out IMO.

why do u think shorts only can cover on NYSE?

April 3, 2008

Journal Register Company Notified by NYSE of Non-Compliance with a Continued Listing Standard

Yardley, PA – Journal Register Company (NYSE:JRC) today announced that on March 31, 2008 the Company was notified by the New York Stock Exchange that the Company had fallen below the NYSE’s continued listing standard relating to minimum share price. The NYSE standard requires that a company’s common stock trade at a minimum average closing price of $1.00 per share during a consecutive 30-day trading period.

Under the NYSE rules, the Company has ten business days to notify the NYSE of its intent to cure this deficiency and six months to cure it or be subject to suspension and delisting. The Company intends to notify the NYSE within the required ten business day period that it intends to cure the deficiency. Under the NYSE rules, the Company’s common stock will continue to be listed on the NYSE during the six month cure period, subject to compliance with the other NYSE continued listing requirements. Although the Company intends to cure its deficiency and to return to compliance with NYSE continued listing requirements, there can be no assurance that it will be able to do so.

How do you get that from the most recent PR? The NYSE is not letting them cure - they are going to be delisted from the NYSE Wednesday morning and will start trading on the OTC. They did notify the NYSE of their intent to cure, but the NYSE still decided to delist (because NYSE can do basically whatever it wants, especially for stocks under $1). They don't have the 6 months to cure, they are being delisted on Monday. This is the same news that came out on Friday, the Company just confirmed today that they are not appealing the decision.

The co. can choose to cure or delist now. Seems they are saying they want to cure. So they will keep trading on the NYSE and try to cure the deficiency.

what about the six months period?

April 3, 2008

Journal Register Company Notified by NYSE of Non-Compliance with a Continued Listing Standard

Yardley, PA – Journal Register Company (NYSE:JRC) today announced that on March 31, 2008 the Company was notified by the New York Stock Exchange that the Company had fallen below the NYSE’s continued listing standard relating to minimum share price. The NYSE standard requires that a company’s common stock trade at a minimum average closing price of $1.00 per share during a consecutive 30-day trading period.

Under the NYSE rules, the Company has ten business days to notify the NYSE of its intent to cure this deficiency and six months to cure it or be subject to suspension and delisting. The Company intends to notify the NYSE within the required ten business day period that it intends to cure the deficiency. Under the NYSE rules, the Company’s common stock will continue to be listed on the NYSE during the six month cure period, subject to compliance with the other NYSE continued listing requirements. Although the Company intends to cure its deficiency and to return to compliance with NYSE continued listing requirements, there can be no assurance that it will be able to do so.

Under the NYSE rules, the Company has ten business days to notify the NYSE of its intent to cure this deficiency and six months to cure it or be subject to suspension and delisting. The Company intends to notify the NYSE within the required ten business day period that it intends to cure the deficiency. Under the NYSE rules, the Company's common stock will continue to be listed on the NYSE during the six month cure period, subject to compliance with the other NYSE continued listing requirements.

Looks like a buyout to me.

Additional risk factors are outlined in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Journal Register Company Receives NYSE Delisting Notification
Journal Register Company (NYSE: JRC) announced today that the New York Stock Exchange (the "NYSE") intends to suspend trading in the Company's common stock prior to the NYSE's opening on April 16, 2008 and that the NYSE will commence procedures to delist the Company's common stock. The NYSE determined to suspend trading based on the abnormally low trading price for the common stock, which closed at $0.265 on April 11, 2008. The Company does not intend to take any further action to appeal the NYSE's decision and therefore, it is expected that the common stock will be delisted after completion by the NYSE of application to the Securities and Exchange Commission. The Company expects trading in its common stock will be transferred to the over-the-counter market following the suspension of trading on the NYSE.

About Journal Register Company

Journal Register Company is a leading U.S. media company. Journal Register Company owns 22 daily newspapers and 302 non-daily publications. Journal Register Company currently operates 229 individual Web sites that are affiliated with the Company's daily newspapers, non-daily publications and its network of employment Web sites. These Web sites can be accessed at www.JournalRegister.com. All of the Company's operations are strategically clustered in six geographic areas: Greater Philadelphia; Michigan; Connecticut; Greater Cleveland; and the Capital-Saratoga and Mid-Hudson regions of New York. The Company owns JobsInTheUS, a network of 20 employment Web sites.

Safe-Harbor

This release contains forward-looking information about Journal Register Company that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. These forward-looking statements involve a number of risks and uncertainties, which could cause actual results to differ materially. These risks and uncertainties include, but are not limited to statements related to the ability of the Company's common stock to trade in the over-the-counter market following suspension of trading on the NYSE. Additional risk factors are outlined in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Add to Digg Bookmark with del.icio.us Add to Newsvine

For more information:
Journal Register Company
790 Township Line Road
Yardley, PA 19067
Gary Struening
Investor Relations
Tel: (215) 504-4200
Fax: (215) 504-4201





Source: Marketwire (April 14, 2008 - 4:29 PM EST)

News by QuoteMedia
www.quotemedia.com

close .31 up 16.98%

JRC UP 7% NEW HIGH of the DAY !!!!

JRC UP 1.43 %%%%%%%%%

yep, bottomed

Looks to be consolidating around .25.

Everyone thought they had a plan for INPC too. LOL. Difference here is the funds buying.

seems no weak hands after suspension news. tells me Lazard has a plan and company will ask for a review

Not yet. Wanted to watch the action a bit first.

Good STRONG BUY here at this levels

are u in zoro?

http://www.cnbc.com/id/15837275?q=jrc

""" JRC """ INSTITUTIONALS BUYING !!!!! Link Below !!!!!

http://www.sec.gov/cgi-bin/browse-edgar?company=&CIK=jrc&filenum=&State=&SIC=&owner=include&action=getcompany

SHORTERS SOLD and INSTITUTIONALS TAKE ALL !!!!!

http://www.shortsqueeze.com/?symbol=jrc&submit=Short+Quote%99

INSTITUTIONALS BUYING !!!!! Link Below !!!!!

http://www.sec.gov/cgi-bin/browse-edgar?company=&CIK=jrc&filenum=&State=&SIC=&owner=include&action=getcompany

SHORTERS SOLD and INSTITUTIONALS TAKE ALL !!!!!

http://www.shortsqueeze.com/?symbol=jrc&submit=Short+Quote%99

Your little secret here could be a real jewel;)

SHORTERS SOLD to INSTITUTIONALS how can they COVER?

$1 plus...Go JRC way oversold @!!

who said $1?

http://www.sec.gov/cgi-bin/browse-edgar?company=&CIK=jrc&filenum=&State=&SIC=&owner=include&action=getcompany

http://phx.corporate-ir.net/phoenix.zhtml?c=80412&p=irol-Sec